Zynex Inc. Stock OTC Bulletin Board
Equities
Advanced Medical Equipment & Technology
Financials (USD)
Sales 2024 * | 227M | Sales 2025 * | 290M | Capitalization | 363M |
---|---|---|---|---|---|
Net income 2024 * | 17M | Net income 2025 * | 32M | EV / Sales 2024 * | 1.45 x |
Net cash position 2024 * | 33.11M | Net cash position 2025 * | 11.06M | EV / Sales 2025 * | 1.21 x |
P/E ratio 2024 * |
23.5
x | P/E ratio 2025 * |
12.1
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 38.54% |
Latest transcript on Zynex Inc.
Managers | Title | Age | Since |
---|---|---|---|
Thomas Sandgaard
CEO | Chief Executive Officer | 65 | 95-12-31 |
Daniel Moorhead
DFI | Director of Finance/CFO | 51 | 17-06-04 |
Anna Lucsok
COO | Chief Operating Officer | 38 | 18-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 74 | 18-01-09 | |
Thomas Sandgaard
CEO | Chief Executive Officer | 65 | 95-12-31 |
Michael D. Cress
BRD | Director/Board Member | 66 | 18-01-09 |
1st Jan change | Capi. | |
---|---|---|
+2.64% | 208B | |
+1.80% | 174B | |
+8.59% | 130B | |
+16.47% | 98.97B | |
-3.42% | 60.46B | |
+12.71% | 51.73B | |
-6.61% | 45.33B | |
-4.53% | 38.9B | |
+9.27% | 38.56B |